Drugs / Whole Agonist-Stimulated T (WAST) cells
Whole Agonist-Stimulated T (WAST) cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07330050 | Dec 2025 → Dec 2026 expected | non-small cell lung carcinoma | Tianjin Medical University Cancer Institute and Hospital | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Whole Agonist-Stimulated T (WAST) cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07330050 ↗ |
| Modality | Cell therapy | “Whole Agonist-Stimulated T (WAST) cells injection” NCT07330050 ↗ |
| Route | Intravenous | “WAST cells (≥4.0 × 10⁹ cells), intravenous infusion, d14, Q3W for 4 cycles.” NCT07330050 ↗ |